Results 211 to 220 of about 47,200 (309)

Exploring Internal Medicine by a Comparative Schematic Analysis of the Long-Term Outcomes of Anticoagulation Therapy in Atrial Fibrillation. [PDF]

Cureus
Gul W, Qaiser S, Abbas SM, Singh D, Sta Ines MCA, Asad L, Aftab Z, Shah MH, Mzahri EUH.   +8 more
europepmc   +1 more source

Direct oral anticoagulants do not affect miR-27a-3p expression, a regulator of coagulation cascade, in atrial fibrillation patients. [PDF]

J Thromb Thrombolysis
Ragia G, Pallikarou M, Michou C, Thomopoulos T, Chalikias G, Trikas A, Tziakas DN, Manolopoulos VG.   +7 more
europepmc   +1 more source

Peri-ablation warfarin vs. dabigatran: different but the same [PDF]

, 2013
Roger A. Winkle, Melissa H. Kong
openalex   +1 more source

Effectiveness and safety of rivaroxaban in patients with atrial fibrillation and heart failure in clinical practice: an indirect comparison of national and international registries. [PDF]

Front Cardiovasc Med
Cepeda JM, Manito N, Recio Mayoral A, Lekuona I, Castillo Orive M, Blanco Labrador E, Blasco MT, Farré N, García Pinilla JM, Jiménez-Candil J, Rafols C, Gomez Doblas JJ.   +11 more
europepmc   +1 more source

Budget impact analysis resulting from the use of dabigatran etexilate in preventing stroke in patients with non-valvular atrial fibrillation in Italy

, 2012
Francesco Saverio Mennini, Sergio Russo, Andrea Marcellusi   +2 more
openalex   +2 more sources

Real life efficacy and safety of dabigatran for stroke prevention in atrial fibrillation: updated results of the prospective NOAC registry (NCT01588119) [PDF]

, 2013
J. Beyer-Westendorf, F. Ebertz, V. Gelbricht, K. Foerster, L. Tittl, S. Werth, C. Koehler   +6 more
openalex   +1 more source

Comparative Analysis of the Net Clinical Benefit of Direct Oral Anticoagulants in Atrial Fibrillation: Systematic Review and Network Meta-analysis of Randomised Controlled Trials. [PDF]

Eur Cardiol
Duy Mai T, Ho THQ, Hoang SV, Nguyen HTT, Pandian J, Nguyen TV, Vu KT, Tran GS, Dao VP, Tran MC, Pham HM.   +10 more
europepmc   +1 more source

Meta-Analysis of Safety of Dabigatran and Warfarin for Treatment of Atrial Fibrillation [PDF]

, 2013
S. Aggarwal, J. Segal
openalex   +1 more source

Oral Anticoagulation Therapy: An Update on Usage and Costs in the Endemic COVID-19 Era. [PDF]

J Clin Med
Favaloro EJ, Pasalic L, Lippi G.
europepmc   +1 more source

New oral antithrombotics: focus on dabigatran, an oral, reversible direct thrombin inhibitor for the prevention and treatment of venous and arterial thromboembolic disorders

, 2012
Ola E. Dahl
openalex   +2 more sources